Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ORLANDI, Ester")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 24 of 24

  • Page / 1
Export

Selection :

  • and

Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profilesARCAINI, Luca; PAULLI, Marco; SCHENA, Claudio et al.Cancer. 2004, Vol 100, Num 1, pp 107-115, issn 0008-543X, 9 p.Article

Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A reviewORLANDI, Ester; PALAZZI, Mauro; PIGNOLI, Emanuele et al.Critical reviews in oncology/hematology. 2010, Vol 73, Num 2, pp 111-125, issn 1040-8428, 15 p.Article

Epstein-Barr virus-positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphomaORLANDI, Ester; PAULLI, Marco; VIGLIO, Alessandra et al.British journal of haematology. 2001, Vol 112, Num 2, pp 373-376, issn 0007-1048Article

Advantages of using thalidomide for the management of patients with refractory myelomaCORSO, Alessandro; LORENZI, Angela; ORLANDI, Ester et al.Haematologica (Roma). 2002, Vol 87, Num 3, pp 327-328, issn 0390-6078Article

Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphomaLAZZARINO, Mario; ARCAINI, Luca; PASSAMONTI, Francesco et al.Oncology. 2005, Vol 68, Num 2-3, pp 146-153, issn 0030-2414, 8 p.Article

Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radiotherapy : analysis of efficacy and long-term toxicityBRUSAMOLINO, Ercole; LUNGHI, Francesca; BERNASCONI, Carlo et al.Haematologica (Roma). 2000, Vol 85, Num 10, pp 1032-1039, issn 0390-6078Article

Drug Resistance and BCR-ABL Kinase Domain Mutations in Philadelphia Chromosome―Positive Acute Lymphoblastic Leukemia From the Imatinib to the Second-Generation Tyrosine Kinase Inhibitor Era: The Main Changes Are in the Type of Mutations, But Not in the Frequency of Mutation InvolvementSOVERINI, Simona; DE BENEDITTIS, Caterina; SICA, Simona et al.Cancer. 2014, Vol 120, Num 7, pp 1002-1009, issn 0008-543X, 8 p.Article

Photoinduced dermatitis and oral lichenoid reaction in a chronic myeloid leukemia patient treated with imatinib mesylateBRAZZELLI, Valeria; MUZIO, Francesca; MANNA, Giambattista et al.Photodermatology photoimmunology & photomedicine. 2012, Vol 28, Num 1, pp 2-5, issn 0905-4383, 4 p.Article

Long-term events in adult patients with clinical stage IA-IIA nonbulky hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin,vinblastine, and dacarbazine and adjuvant radiotherapy : A single-institution 15-year follow-upBRUSAMOLINO, Ercole; BAIO, Ambrogia; ORLANDI, Ester et al.Clinical cancer research. 2006, Vol 12, Num 21, pp 6487-6493, issn 1078-0432, 7 p.Article

Pityriasis rosea-like eruption during treatment with imatinib mesylate : Description of 3 casesBRAZZELLI, Valeria; PRESTINARI, Francesca; ROVEDA, Elena et al.Journal of the American Academy of Dermatology. 2005, Vol 53, Num 5, pp S240-S243, issn 0190-9622, SUPArticle

Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinomaBOSSI, Paolo; PERRONE, Federica; POTEPAN, Paolo et al.Oral oncology (1997). 2013, Vol 49, Num 5, pp 413-419, issn 1368-8375, 7 p.Article

Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitorsSOVERINI, Simona; GNANI, Alessandra; LACOBUCCI, Ilaria et al.Blood. 2009, Vol 114, Num 10, pp 2168-2171, issn 0006-4971, 4 p.Article

Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infectionAMBROSETTI, Achille; ZANOTTI, Roberta; D'ADDA, Mariella et al.British journal of haematology. 2004, Vol 126, Num 1, pp 43-49, issn 0007-1048, 7 p.Article

Primary cutaneous large B-cell lymphoma of the leg: Histogenetic analysis of a controversial clinicopathologic entityPAULLI, Marco; VIGLIO, Alessandra; ORLANDI, Ester et al.Human pathology. 2002, Vol 33, Num 9, pp 937-943, issn 0046-8177Article

Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patientsCORSO, Alessandro; ARCAINI, Luca; LAZZARINO, Mario et al.Haematologica (Roma). 2001, Vol 86, Num 4, pp 394-398, issn 0390-6078Article

Efficacy of pipobroman in the treatment of polycythemia vera : long-term results in 163 patientsPASSAMONTI, Francesco; BRUSAMOLINO, Ercole; LAZZARINO, Mario et al.Haematologica (Roma). 2000, Vol 85, Num 10, pp 1011-1018, issn 0390-6078Article

Stereotyped patterns of B-cell receptor in splenic marginal zone lymphomaZIBELLINI, Silvia; CAPELLO, Daniela; BALDING, Luca et al.Haematologica (Roma). 2010, Vol 95, Num 10, pp 1792-1796, issn 0390-6078, 5 p.Article

Risk of second cancer in nongastric marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue : A population-based study from northern ItalyARCAINI, Luca; BURCHERI, Sara; LUCIONI, Marco et al.Clinical cancer research. 2007, Vol 13, Num 1, pp 182-186, issn 1078-0432, 5 p.Article

Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of philadelphia-positive patients : By the GIMEMA working party on chronic myeloid leukemiaSOVERINI, Simona; COLAROSSI, Sabrina; RADAELLI, Franca et al.Clinical cancer research. 2006, Vol 12, Num 24, pp 7374-7379, issn 1078-0432, 6 p.Article

Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemiaPASSAMONTI, Francesco; RUMI, Elisa; CAZZOLA, Mario et al.The American journal of medicine. 2004, Vol 117, Num 10, pp 755-761, issn 0002-9343, 7 p.Article

Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemiaPASSAMONTI, Francesco; MALABARBA, Lucia; PASCUTTO, Cristiana et al.Haematologica (Roma). 2003, Vol 88, Num 1, pp 13-18, issn 0390-6078, 6 p.Article

Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosisPASSAMONTI, Francesco; MALABARBA, Lucia; CAZZOLA, Mario et al.British journal of haematology. 2002, Vol 116, Num 4, pp 855-861, issn 0007-1048Article

Translocation (8;16) in a patient with acute myelomonocytic leukemia, occurring after treatment with fludarabine for a low-grade non-Hodgkin's lymphomaBERNASCONI, Paolo; ORLANDI, Ester; BERNASCONI, Carlo et al.Haematologica (Roma). 2000, Vol 85, Num 10, pp 1087-1091, issn 0390-6078Article

Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphomaRINALDI, Andrea; AFUA ADJEIWAA MENSAH; CAVALLI, Franco et al.British journal of haematology. 2013, Vol 163, Num 2, pp 194-204, issn 0007-1048, 11 p.Article

  • Page / 1